Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Gastrointest Cancer ; 55(2): 965-968, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38175385

ABSTRACT

PURPOSE: Renal injury is common in cancer patients and its etiology is multifactorial. Different patterns of renal histological lesions have been described in relation to oncologic treatments, notably acute tubular necrosis and tubulointerstitial nephritis, but also thrombotic microangiopathy (TMA). METHODS: We report a case of TMA secondary to capecitabine in an 82-year-old woman diagnosed with localized colon adenocarcinoma. RESULTS: The patient, with previous normal kidney function, presented with renal impairment during the fourth cycle of chemotherapy. After potential nephrotoxic factors were ruled out, capecitabine was discontinued and a kidney biopsy was performed, which displayed TMA lesions. An improvement in renal function was observed after definitive cessation of cytotoxic chemotherapy. Although rare, renal toxicity in the form of TMA may be associated with the use of cytotoxic agents such as gemcitabine, but there is no reported evidence of its association to capecitabine. Early withdrawal of the drug and nephrology consultation is necessary to prevent irreversible damage. CONCLUSION: We describe, to our knowledge, the first case reported in the literature regarding the possible association of TMA and capecitabine.


Subject(s)
Antimetabolites, Antineoplastic , Capecitabine , Thrombotic Microangiopathies , Humans , Capecitabine/adverse effects , Female , Thrombotic Microangiopathies/chemically induced , Thrombotic Microangiopathies/pathology , Thrombotic Microangiopathies/diagnosis , Aged, 80 and over , Antimetabolites, Antineoplastic/adverse effects , Adenocarcinoma/drug therapy , Adenocarcinoma/pathology , Colonic Neoplasms/drug therapy , Colonic Neoplasms/pathology
2.
Eat Weight Disord ; 27(7): 2931-2935, 2022 Oct.
Article in English | MEDLINE | ID: mdl-35553381

ABSTRACT

BACKGROUND: Anorexia nervosa is frequently associated with alcohol use disorder. Both of them may adversely affect almost every body system, leading to worse clinical outcomes and high mortality risk. Nonetheless, there is little evidence interrelating anorexia nervosa, alcohol use disorder, and kidney failure. CASE: We report a case of a 30-year-old male with multi-organ involvement at admission, including pancytopenia, electrolyte alterations, impaired liver function, and renal failure. The kidney biopsy revealed calcium phosphate crystalline nephropathy and IgA nephropathy. The bone marrow biopsy and aspiration showed a hypocellular bone marrow and a focal spindle cell infiltrate with atypical vascular proliferation. Nonspecific liver disease was revealed by ultrasound. Further investigation was performed, uncovering a possible masked diagnosis of anorexia nervosa and alcohol use disorder. With the restoration of adequate nutrition and the withdrawal of possible external triggers, a partial recovery was achieved. CONCLUSIONS: Anorexia nervosa and alcohol use disorder may promote tissue injury, including kidney failure, specifically calcium phosphate crystalline nephropathy and IgA nephropathy. This multi-organ involvement may lose its reversibility if anorexia nervosa and alcohol use disorder remain persistent. An early diagnosis and a successful multidisciplinary approach may prevent life-threatening complications. LEVEL OF EVIDENCE: Level V, case report.


Subject(s)
Alcoholism , Anorexia Nervosa , Glomerulonephritis, IGA , Renal Insufficiency , Adult , Anorexia Nervosa/complications , Biopsy , Calcium Phosphates , Electrolytes , Glomerulonephritis, IGA/complications , Humans , Kidney , Male , Phosphates , Renal Insufficiency/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...